Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/107661
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Grijalvo, Santiago | - |
dc.contributor.author | Alagia, Adele | - |
dc.contributor.author | Jorge, Andreia F. | - |
dc.contributor.author | Eritja, Ramon | - |
dc.date.accessioned | 2023-07-26T10:02:04Z | - |
dc.date.available | 2023-07-26T10:02:04Z | - |
dc.date.issued | 2018-02-06 | - |
dc.identifier.issn | 2073-4425 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/107661 | - |
dc.description.abstract | Oligonucleotide-based therapy has become an alternative to classical approaches in the search of novel therapeutics involving gene-related diseases. Several mechanisms have been described in which demonstrate the pivotal role of oligonucleotide for modulating gene expression. Antisense oligonucleotides (ASOs) and more recently siRNAs and miRNAs have made important contributions either in reducing aberrant protein levels by sequence-specific targeting messenger RNAs (mRNAs) or restoring the anomalous levels of non-coding RNAs (ncRNAs) that are involved in a good number of diseases including cancer. In addition to formulation approaches which have contributed to accelerate the presence of ASOs, siRNAs and miRNAs in clinical trials; the covalent linkage between non-viral vectors and nucleic acids has also added value and opened new perspectives to the development of promising nucleic acid-based therapeutics. This review article is mainly focused on the strategies carried out for covalently modifying siRNA and miRNA molecules. Examples involving cell-penetrating peptides (CPPs), carbohydrates, polymers, lipids and aptamers are discussed for the synthesis of siRNA conjugates whereas in the case of miRNA-based drugs, this review article makes special emphasis in using antagomiRs, locked nucleic acids (LNAs), peptide nucleic acids (PNAs) as well as nanoparticles. The biomedical applications of siRNA and miRNA conjugates are also discussed. | pt |
dc.language.iso | eng | pt |
dc.publisher | MDPI | pt |
dc.relation | This work was supported by the Ministerio de Economía, Industria y Competitividad (CTQ2014-52588-R, CTQ2017-84415-R, RTC-2014-2038-1), Generalitat de Catalunya (2014/SGR/624) and the Instituto de Salud Carlos III (ISCIII) (CB06_01_0019). CIBER-BBN is an initiative funded by the VI National R + D + i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER actions and financed by ISCIII with assistance from the European Regional Development Fund. A.F.J. acknowledges Fundaçao para a Ciência e Tecnologia (FCT), Portugal, for financial support regarding post-doctoral grant SFRH/BDP/104544/2014. CQC is supported by FCT through the project No. 007630UID/QUI/00313/2013, co-funded by COMPETE2020-UE. | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject | covalent approach | pt |
dc.subject | gene delivery | pt |
dc.subject | gene therapy | pt |
dc.subject | non-coding RNA | pt |
dc.subject | miRNA technology | pt |
dc.subject | nucleic acid conjugates | pt |
dc.subject | RNA interference | pt |
dc.title | Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates | pt |
dc.type | article | - |
degois.publication.firstPage | 74 | pt |
degois.publication.issue | 2 | pt |
degois.publication.title | Genes | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.3390/genes9020074 | pt |
degois.publication.volume | 9 | pt |
dc.date.embargo | 2018-02-06 | * |
uc.date.periodoEmbargo | 0 | pt |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | I&D CQC - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Covalent-strategies-for-targeting-messenger-and-noncoding-RNAs-An-updated-review-on-siRNA-miRNA-and-antimiR-conjugatesGenes.pdf | 3.93 MB | Adobe PDF | View/Open |
Page view(s)
45
checked on Aug 28, 2024
Download(s)
18
checked on Aug 28, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License